The financial assistance provided by Universiti Putra Malaysia under Putra Grant (GP-IPS/2016/9481700) was gratefully acknowledged.
Ahmed, M., Ramadan, W., Rambhu, D., and Shakeel, F. (2008). Potential of nanoemulsions for intravenous delivery of rifampicin. Pharmazie, 63, 806–811.
Allen, M. J., Edberg, S. C., and Reasoner, D. J. (2004). Heterotrophic plate count bacteria - what is their significance in drinking water? International Journal of Food Microbiology, 92, 265–274.
Bouwstra, J. A., and Ponec, M. (2006). The skin barrier in healthy and diseased state, 1758, 2080–2095.
Burroni, A. G., Fassino, M., Torti, A., and Visentin, E. (2015). How do disease perception , treatment features , and dermatologist – patient relationship impact on patients assuming topical treatment ? An Italian survey. DovePress, 6, 9–17.
Cevc, G., and Vierl, U. (2010). Nanotechnology and the transdermal route: A state of the art review and critical appraisal. Journal of Controlled Release, 141, 277–299.
Gisondi, P., Galvan, A., Idolazzi, L., and Girolomoni, G. (2015). Management of moderate to severe psoriasis in patients with metabolic comorbidities. Frontiers in Medicine (Vol. 2).
Italia, J. L., Bhardwaj, V., and Kumar, M. N. V. R. (2006). Disease , destination , dose and delivery aspects of ciclosporin : the state of the art. Drug Discovery Today, 11, 846–854.
Kim, G. K., and Rosso, J. Q. D. (2010). Drug-Provoked Psoriasis : Is it drug induced or drug aggravated ? Understanding pathophysiology and clinical relevance. The Journal of Clinical and Aesthetic Dermatology, 3, 32–38.
Mitragotri, S. (2003). Modeling skin permeability to hydrophilic and hydrophobic solutes based on four permeation pathways. Journal of Controlled Release, 86, 69–92.
Ngan, C. L., Basri, M., Tripathy, M., Abedi, R., and Abdul-Malek, E. (2015). Skin intervention of fullerene-integrated nanoemulsion in structural and collagen regeneration against skin aging. European Journal of Pharmaceutical Sciences, 70, 22–28.
Puigdemont, A., Brazís, P., Ordeix, L., Dalmau, A., Fuertes, E., Olivar, A., … Ravera, I. (2013). Efficacy of a new topical cyclosporine A formulation in the treatment of atopic dermatitis in dogs. The Veterinary Journal, 197(2), 280–285.
Rahman, M., Alam, K., Zaki Ahmad, M., Gupta, G., Afzal, M., Akhter, S., … Anwar, F. (2012). Classical to Current Approach for Treatment of Psoriasis: A Review. Endocrine, Metabolic & Immune Disorders - Drug Targets, 12, 287–302.
Rawlings, A. V, and Lombard, K. J. (2012). A review on the extensive skin benefits of mineral oil. International Journal of Cosmetic Science, 34, 511–518.
Rezzani, R., Buffoli, B., Rodella, L., Stacchiotti, A., and Bianchi, R. (2005). Protective role of melatonin in cyclosporine A-induced oxidative stress in rat liver. International Immunopharmacology, 5, 1397–1405.
Salim, N., Ahmad, N., Musa, S. H., Hashim, R., Tadros, T. F., and Basri, M. (2016). Nanoemulsion as a topical delivery system of antipsoriatic drugs. Royal Society of ChemistryRSC Advances, 6, 6234–6250.
Schön, M. P., and Boehncke, W.-H. (2005). Psoriasis. The New England Journal of Medicine, 352, 1899–1912.
Solans, C., Izquierdo, P., Nolla, J., Azemar, N., and Garcia-Celma, M. J. (2005). Nano-emulsions. Current Opinion in Colloid and Interface Science, 10, 102–110.
Suresh, P. K., Singh, P., and Saraf, S. (2013). Novel topical drug carriers as a tool for treatment of psoriasis: Progress and advances. African Journal of Pharmacy and Pharmacology, 7, 138–147.
Tang, S. Y., Manickam, S., Wei, T. K., and Nashiru, B. (2012). Formulation development and optimization of a novel Cremophore EL-based nanoemulsion using ultrasound cavitation. Ultrasonics Sonochemistry, 19, 330–345.